{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:09:18Z","timestamp":1773299358746,"version":"3.50.1"},"reference-count":118,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.breast.2013.04.006","type":"journal-article","created":{"date-parts":[[2013,5,11]],"date-time":"2013-05-11T19:45:13Z","timestamp":1368301513000},"page":"375-382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Practical aspects of genetic counseling in breast cancer: Lights and shadows"],"prefix":"10.1016","volume":"22","author":[{"given":"Alexandre","family":"Christinat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Pagani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.breast.2013.04.006_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell."},{"issue":"1","key":"10.1016\/j.breast.2013.04.006_bib2","first-page":"10","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"issue":"6559","key":"10.1016\/j.breast.2013.04.006_bib3","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/378789a0","article-title":"Identification of the breast cancer susceptibility gene BRCA2","volume":"378","author":"Wooster","year":"1995","journal-title":"Nature"},{"issue":"5182","key":"10.1016\/j.breast.2013.04.006_bib4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1","volume":"266","author":"Miki","year":"1994","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.breast.2013.04.006_bib5","doi-asserted-by":"crossref","first-page":"562","DOI":"10.6004\/jnccn.2010.0043","article-title":"Genetic\/familial high-risk assessment: breast and ovarian","volume":"8","author":"Daly","year":"2010","journal-title":"J Natl Compr Canc Netw"},{"issue":"12","key":"10.1016\/j.breast.2013.04.006_bib6","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nrc2054","article-title":"Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations","volume":"7","author":"Fackenthal","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"16","key":"10.1016\/j.breast.2013.04.006_bib7","first-page":"3663","article-title":"High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients","volume":"56","author":"Johannesdottir","year":"1996","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.breast.2013.04.006_bib8","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","article-title":"Meta-analysis of BRCA1 and BRCA2 penetrance","volume":"25","author":"Chen","year":"2007","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.breast.2013.04.006_bib9","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10549-010-0805-3","article-title":"Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age","volume":"124","author":"van der Kolk","year":"2010","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"10.1016\/j.breast.2013.04.006_bib10","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22\u00a0studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet."},{"issue":"3","key":"10.1016\/j.breast.2013.04.006_bib11","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","article-title":"Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium","volume":"62","author":"Ford","year":"1998","journal-title":"Am J Hum Genet."},{"issue":"12","key":"10.1016\/j.breast.2013.04.006_bib12","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1200\/JCO.2004.04.033","article-title":"Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers","volume":"22","author":"Metcalfe","year":"2004","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.breast.2013.04.006_bib13","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1200\/JCO.2004.05.055","article-title":"Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature","volume":"22","author":"Liede","year":"2004","journal-title":"J Clin Oncol"},{"issue":"20","key":"10.1016\/j.breast.2013.04.006_bib14","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1056\/NEJMra0802968","article-title":"Inherited susceptibility to common cancers","volume":"359","author":"Foulkes","year":"2008","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.breast.2013.04.006_bib15","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1158\/1078-0432.CCR-08-1822","article-title":"Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations","volume":"15","author":"Agalliu","year":"2009","journal-title":"Clin Cancer Res."},{"issue":"9","key":"10.1016\/j.breast.2013.04.006_bib16","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1158\/1078-0432.CCR-03-0604","article-title":"BRCA mutations and risk of prostate cancer in Ashkenazi Jews","volume":"10","author":"Kirchhoff","year":"2004","journal-title":"Clin Cancer Res."},{"issue":"7","key":"10.1016\/j.breast.2013.04.006_bib17","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1158\/1078-0432.CCR-09-2871","article-title":"Germline BRCA mutations denote a clinicopathologic subset of prostate cancer","volume":"16","author":"Gallagher","year":"2010","journal-title":"Clin Cancer Res."},{"issue":"9","key":"10.1016\/j.breast.2013.04.006_bib18","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/jmg.2004.028829","article-title":"Cancer risks in BRCA2 families: estimates for sites other than breast and ovary","volume":"42","author":"van Asperen","year":"2005","journal-title":"J Med Genet."},{"issue":"8","key":"10.1016\/j.breast.2013.04.006_bib19","first-page":"2011","article-title":"Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study","volume":"59","author":"Armes","year":"1999","journal-title":"Cancer Res."},{"issue":"26","key":"10.1016\/j.breast.2013.04.006_bib20","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1200\/JCO.2008.16.6231","article-title":"Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer","volume":"26","author":"Atchley","year":"2008","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.breast.2013.04.006_bib21","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1158\/1078-0432.CCR-10-2560","article-title":"Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer","volume":"17","author":"Gonzalez-Angulo","year":"2011","journal-title":"Clin Cancer Res."},{"key":"10.1016\/j.breast.2013.04.006_bib22","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2407-9-86","article-title":"The prevalence of BRCA1 mutations among young women with triple-negative breast cancer","volume":"9","author":"Young","year":"2009","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.breast.2013.04.006_bib23","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2353\/jmoldx.2009.080137","article-title":"A rapid and reliable test for BRCA1 and BRCA2 founder mutation analysis in paraffin tissue using pyrosequencing","volume":"11","author":"Zhang","year":"2009","journal-title":"J Mol Diagn"},{"issue":"1","key":"10.1016\/j.breast.2013.04.006_bib24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2353\/jmoldx.2010.090023","article-title":"Detection of BRCA1 and BRCA2 Ashkenazi Jewish founder mutations in formalin-fixed paraffin-embedded tissues using conventional PCR and heteroduplex\/amplicon size differences","volume":"12","author":"Mangold","year":"2010","journal-title":"J Mol Diagn"},{"issue":"4","key":"10.1016\/j.breast.2013.04.006_bib25","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1200\/JCO.2007.12.5922","article-title":"CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls","volume":"26","author":"Weischer","year":"2008","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.breast.2013.04.006_bib26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10897-011-9462-x","article-title":"Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors","volume":"21","author":"Riley","year":"2012","journal-title":"J Genet Couns"},{"issue":"5","key":"10.1016\/j.breast.2013.04.006_bib27","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1200\/JCO.2009.27.0660","article-title":"American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility","volume":"28","author":"Robson","year":"2010","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.breast.2013.04.006_bib28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1023\/B:JOGC.0000018821.48330.77","article-title":"Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors","volume":"13","author":"Trepanier","year":"2004","journal-title":"J Genet Couns"},{"issue":"5","key":"10.1016\/j.breast.2013.04.006_bib29","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s10897-008-9169-9","article-title":"Standardized human pedigree nomenclature: update and assessment of the recommendations of the National Society of Genetic Counselors","volume":"17","author":"Bennett","year":"2008","journal-title":"J Genet Couns"},{"issue":"159","key":"10.1016\/j.breast.2013.04.006_bib30","first-page":"1","article-title":"Collection and use of cancer family history in primary care","author":"Qureshi","year":"2007","journal-title":"Evid Rep Technol Assess (Full Rep)"},{"issue":"4","key":"10.1016\/j.breast.2013.04.006_bib31","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.suc.2008.05.003","article-title":"Genetic testing for cancer susceptibility","volume":"88","author":"Calzone","year":"2008","journal-title":"Surg Clin North Am."},{"issue":"Suppl 6","key":"10.1016\/j.breast.2013.04.006_bib32","doi-asserted-by":"crossref","first-page":"vi31","DOI":"10.1093\/annonc\/mdr373","article-title":"BRCA in breast cancer: ESMO Clinical Practice Guidelines","volume":"22","author":"Balmana","year":"2011","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.breast.2013.04.006_bib33","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1200\/JCO.2002.20.6.1480","article-title":"Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals","volume":"20","author":"Frank","year":"2002","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.breast.2013.04.006_bib34","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.4065\/mcp.2010.0414","article-title":"Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer","volume":"85","author":"Pruthi","year":"2010","journal-title":"Mayo Clin Proc."},{"issue":"3","key":"10.1016\/j.breast.2013.04.006_bib35","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrc1301","article-title":"Genetic testing for cancer susceptibility: the promise and the pitfalls","volume":"4","author":"Lerman","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"24","key":"10.1016\/j.breast.2013.04.006_bib36","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1001\/jama.1996.03530480027036","article-title":"BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes","volume":"275","author":"Lerman","year":"1996","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.breast.2013.04.006_bib37","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.tig.2010.08.001","article-title":"Illusions of scientific legitimacy: misrepresented science in the direct-to-consumer genetic-testing marketplace","volume":"26","author":"Vashlishan Murray","year":"2010","journal-title":"Trends Genet."},{"issue":"2","key":"10.1016\/j.breast.2013.04.006_bib38","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10549-008-0070-x","article-title":"Differences and similarities in breast cancer risk assessment models in clinical practice: which model to choose?","volume":"115","author":"Jacobi","year":"2009","journal-title":"Breast Cancer Res Treat"},{"issue":"27","key":"10.1016\/j.breast.2013.04.006_bib39","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1200\/JCO.2010.28.0719","article-title":"Expanding the criteria for BRCA mutation testing in breast cancer survivors","volume":"28","author":"Kwon","year":"2010","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.breast.2013.04.006_bib40","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1200\/JCO.2005.02.2368","article-title":"Assessing BRCA carrier probabilities in extended families","volume":"24","author":"Barcenas","year":"2006","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.breast.2013.04.006_bib41","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/sj.bjc.6602175","article-title":"The BOADICEA model of genetic susceptibility to breast and ovarian cancer","volume":"91","author":"Antoniou","year":"2004","journal-title":"Br J Cancer"},{"issue":"11","key":"10.1016\/j.breast.2013.04.006_bib42","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1200\/JCO.2002.05.121","article-title":"BRCAPRO validation, sensitivity of genetic testing of BRCA1\/BRCA2, and prevalence of other breast cancer susceptibility genes","volume":"20","author":"Berry","year":"2002","journal-title":"J Clin Oncol"},{"issue":"20","key":"10.1016\/j.breast.2013.04.006_bib43","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJM199705153362002","article-title":"BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer","volume":"336","author":"Couch","year":"1997","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.breast.2013.04.006_bib44","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1001\/jama.1997.03550150046034","article-title":"BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing","volume":"278","author":"Shattuck-Eidens","year":"1997","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.breast.2013.04.006_bib45","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/sim.1668","article-title":"A breast cancer prediction model incorporating familial and personal risk factors","volume":"23","author":"Tyrer","year":"2004","journal-title":"Stat Med"},{"issue":"4","key":"10.1016\/j.breast.2013.04.006_bib46","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1200\/JCO.2005.01.9737","article-title":"Optimal selection of individuals for BRCA mutation testing: a comparison of available methods","volume":"24","author":"James","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2013.04.006_bib47","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1471-2350-9-116","article-title":"Selecting a BRCA risk assessment model for use in a familial cancer clinic","volume":"9","author":"Panchal","year":"2008","journal-title":"BMC Med Genet."},{"issue":"6","key":"10.1016\/j.breast.2013.04.006_bib48","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1136\/jmg.2003.017996","article-title":"A new scoring system for the chances of identifying a BRCA1\/2 mutation outperforms existing models including BRCAPRO","volume":"41","author":"Evans","year":"2004","journal-title":"J Med Genet."},{"issue":"11","key":"10.1016\/j.breast.2013.04.006_bib49","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/jnci\/94.11.844","article-title":"Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO","volume":"94","author":"Euhus","year":"2002","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.breast.2013.04.006_bib50","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/jmg.2003.013623","article-title":"Evaluation of widely used models for predicting BRCA1 and BRCA2 mutations","volume":"41","author":"Marroni","year":"2004","journal-title":"J Med Genet."},{"issue":"2","key":"10.1016\/j.breast.2013.04.006_bib51","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1200\/JCO.2002.20.2.514","article-title":"Impact of BRCA1\/BRCA2 mutation testing on psychologic distress in a clinic-based sample","volume":"20","author":"Schwartz","year":"2002","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.breast.2013.04.006_bib52","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/ajmg.a.10844","article-title":"What do ratings of cancer-specific distress mean among women at high risk of breast and ovarian cancer?","volume":"116A","author":"Coyne","year":"2003","journal-title":"Am J Med Genet A"},{"issue":"4","key":"10.1016\/j.breast.2013.04.006_bib53","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1037\/a0014778","article-title":"Emotional distress following genetic testing for hereditary breast and ovarian cancer: a meta-analytic review","volume":"28","author":"Hamilton","year":"2009","journal-title":"Health Psychol"},{"issue":"6","key":"10.1016\/j.breast.2013.04.006_bib54","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.breast.2012.02.004","article-title":"What factors may influence psychological well being at three months and one year post BRCA genetic result disclosure?","volume":"21","author":"Bosch","year":"2012","journal-title":"Breast"},{"issue":"4","key":"10.1016\/j.breast.2013.04.006_bib55","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1158\/0008-5472.CAN-05-3546","article-title":"Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance","volume":"66","author":"Chenevix-Trench","year":"2006","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.breast.2013.04.006_bib56","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.292.11.1317","article-title":"Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination","volume":"292","author":"Warner","year":"2004","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.breast.2013.04.006_bib57","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1002\/cncr.20221","article-title":"The development of interval breast malignancies in patients with BRCA mutations","volume":"100","author":"Komenaka","year":"2004","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.breast.2013.04.006_bib58","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1200\/JCO.2002.20.5.1260","article-title":"Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers","volume":"20","author":"Scheuer","year":"2002","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.breast.2013.04.006_bib59","first-page":"75","article-title":"American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography","volume":"57","author":"Saslow","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.breast.2013.04.006_bib60","article-title":"Genetic\/Familial High-Risk Assessment: Breast and Ovarian. Version 1.2012","author":"NCCN","year":"2012","journal-title":"National Comprehensive Cancer Network Guidelines"},{"issue":"5","key":"10.1016\/j.breast.2013.04.006_bib61","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa031759","article-title":"Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition","volume":"351","author":"Kriege","year":"2004","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.breast.2013.04.006_bib62","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/jnci\/93.14.1095","article-title":"Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer","volume":"93","author":"Stoutjesdijk","year":"2001","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.breast.2013.04.006_bib63","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/jnci\/95.7.556","article-title":"Mammographic breast density and family history of breast cancer","volume":"95","author":"Ziv","year":"2003","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"10.1016\/j.breast.2013.04.006_bib64","doi-asserted-by":"crossref","first-page":"671","DOI":"10.7326\/0003-4819-148-9-200805060-00007","article-title":"Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer","volume":"148","author":"Warner","year":"2008","journal-title":"Ann Intern Med"},{"issue":"17","key":"10.1016\/j.breast.2013.04.006_bib65","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1002\/cncr.25971","article-title":"Effectiveness of alternating mammography and magnetic resonance imaging for screening women with deleterious BRCA mutations at high risk of breast cancer","volume":"117","author":"Le-Petross","year":"2011","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.breast.2013.04.006_bib66","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1200\/JCO.2002.10.101","article-title":"Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1\/2 mutations: an updated decision analysis","volume":"20","author":"Grann","year":"2002","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.breast.2013.04.006_bib67","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1200\/JCO.2009.22.7991","article-title":"Survival analysis of cancer risk reduction strategies for BRCA1\/2 mutation carriers","volume":"28","author":"Kurian","year":"2010","journal-title":"J Clin Oncol"},{"issue":"20","key":"10.1016\/j.breast.2013.04.006_bib68","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1001\/jama.295.20.2374","article-title":"Cost-effectiveness of screening BRCA1\/2 mutation carriers with breast magnetic resonance imaging","volume":"295","author":"Plevritis","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.breast.2013.04.006_bib69","doi-asserted-by":"crossref","first-page":"e5660","DOI":"10.1136\/bmj.e5660","article-title":"Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1\/2 mutations: retrospective cohort study (GENE-RAD-RISK)","volume":"345","author":"Pijpe","year":"2012","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.breast.2013.04.006_bib70","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S1470-2045(06)70624-6","article-title":"Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study","volume":"7","author":"Narod","year":"2006","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.breast.2013.04.006_bib71","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/jmg.2008.058248","article-title":"Screening for familial ovarian cancer: poor survival of BRCA1\/2 related cancers","volume":"46","author":"Evans","year":"2009","journal-title":"J Med Genet."},{"issue":"12","key":"10.1016\/j.breast.2013.04.006_bib72","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/j.1471-0528.2007.01499.x","article-title":"Annual surveillance by CA125 and transvaginal ultrasound for ovarian cancer in both high-risk and population risk women is ineffective","volume":"114","author":"Woodward","year":"2007","journal-title":"BJOG"},{"issue":"2","key":"10.1016\/j.breast.2013.04.006_bib73","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199901143400201","article-title":"Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer","volume":"340","author":"Hartmann","year":"1999","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.breast.2013.04.006_bib74","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/jnci\/93.21.1633","article-title":"Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers","volume":"93","author":"Hartmann","year":"2001","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.breast.2013.04.006_bib75","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1200\/JCO.2004.04.188","article-title":"Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group","volume":"22","author":"Rebbeck","year":"2004","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.breast.2013.04.006_bib76","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.breast.2013.04.006_bib77","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM200107193450301","article-title":"Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation","volume":"345","author":"Meijers-Heijboer","year":"2001","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.breast.2013.04.006_bib78","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers","volume":"101","author":"Rebbeck","year":"2009","journal-title":"J Natl Cancer Inst"},{"issue":"21","key":"10.1016\/j.breast.2013.04.006_bib79","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations","volume":"346","author":"Rebbeck","year":"2002","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.breast.2013.04.006_bib80","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","article-title":"Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation","volume":"346","author":"Kauff","year":"2002","journal-title":"N Engl J Med"},{"issue":"30","key":"10.1016\/j.breast.2013.04.006_bib81","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1200\/JCO.2004.00.7138","article-title":"Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study","volume":"23","author":"Eisen","year":"2005","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.breast.2013.04.006_bib82","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1200\/JCO.2007.13.9626","article-title":"Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study","volume":"26","author":"Kauff","year":"2008","journal-title":"J Clin Oncol"},{"issue":"18","key":"10.1016\/j.breast.2013.04.006_bib83","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1001\/jama.286.18.2251","article-title":"Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial","volume":"286","author":"King","year":"2001","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.breast.2013.04.006_bib84","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1002\/ijc.21536","article-title":"Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update","volume":"118","author":"Gronwald","year":"2006","journal-title":"Int J Cancer"},{"issue":"23","key":"10.1016\/j.breast.2013.04.006_bib85","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1200\/JCO.2003.02.107","article-title":"Tamoxifen as chemoprevention in BRCA1 and BRCA2 mutation carriers with breast cancer: a pilot survey of physicians","volume":"21","author":"Peshkin","year":"2003","journal-title":"J Clin Oncol"},{"issue":"25","key":"10.1016\/j.breast.2013.04.006_bib86","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1056\/NEJMoa1103507","article-title":"Exemestane for breast-cancer prevention in postmenopausal women","volume":"364","author":"Goss","year":"2011","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.breast.2013.04.006_bib87","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S1470-2045(11)70030-4","article-title":"Preventive therapy for breast cancer: a consensus statement","volume":"12","author":"Cuzick","year":"2011","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.breast.2013.04.006_bib88","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/j.ejca.2010.04.018","article-title":"Oral contraceptive use and breast or ovarian cancer risk in BRCA1\/2 carriers: a meta-analysis","volume":"46","author":"Iodice","year":"2010","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.breast.2013.04.006_bib89","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10549-006-9161-8","article-title":"Diet, lifestyle and BRCA-related breast cancer risk among French-Canadians","volume":"98","author":"Nkondjock","year":"2006","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.breast.2013.04.006_bib90","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10549-006-9371-0","article-title":"Diet quality and BRCA-associated breast cancer risk","volume":"103","author":"Nkondjock","year":"2007","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"10.1016\/j.breast.2013.04.006_bib91","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nrclinonc.2010.175","article-title":"The role of BRCA mutation testing in determining breast cancer therapy","volume":"7","author":"Trainer","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"10.1016\/j.breast.2013.04.006_bib92","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1200\/JCO.2004.04.086","article-title":"Impact of BRCA1\/BRCA2 counseling and testing on newly diagnosed breast cancer patients","volume":"22","author":"Schwartz","year":"2004","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.breast.2013.04.006_bib93","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1245\/s10434-010-1136-7","article-title":"Contralateral prophylactic mastectomy is associated with a survival advantage in high-risk women with a personal history of breast cancer","volume":"17","author":"Boughey","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.breast.2013.04.006_bib94","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/jnci\/djq018","article-title":"Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients","volume":"102","author":"Bedrosian","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"10.1016\/j.breast.2013.04.006_bib95","article-title":"Prophylactic mastectomy for the prevention of breast cancer","author":"Lostumbo","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.breast.2013.04.006_bib96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bjs.6463","article-title":"Prophylactic mastectomy and the timing of breast reconstruction","volume":"96","author":"Morrow","year":"2009","journal-title":"Br J Surg"},{"issue":"9316","key":"10.1016\/j.breast.2013.04.006_bib97","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/S0140-6736(02)08434-9","article-title":"Outcome of conservatively managed early-onset breast cancer by BRCA1\/2 status","volume":"359","author":"Haffty","year":"2002","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.breast.2013.04.006_bib98","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1200\/JCO.2005.02.7888","article-title":"Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1\/2-associated stage I\/II breast cancer","volume":"24","author":"Pierce","year":"2006","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.breast.2013.04.006_bib99","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/annonc\/mdj095","article-title":"Survival and prognostic factors in BRCA1-associated breast cancer","volume":"17","author":"Brekelmans","year":"2006","journal-title":"Ann Oncol"},{"issue":"58","key":"10.1016\/j.breast.2013.04.006_bib100","doi-asserted-by":"crossref","first-page":"8981","DOI":"10.1038\/sj.onc.1206176","article-title":"Homologous repair of DNA damage and tumorigenesis: the BRCA connection","volume":"21","author":"Jasin","year":"2002","journal-title":"Oncogene"},{"issue":"9737","key":"10.1016\/j.breast.2013.04.006_bib101","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0140-6736(10)60892-6","article-title":"Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial","volume":"376","author":"Tutt","year":"2010","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.breast.2013.04.006_bib102","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa0900212","article-title":"Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers","volume":"361","author":"Fong","year":"2009","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.breast.2013.04.006_bib103","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S1470-2045(11)70214-5","article-title":"Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study","volume":"12","author":"Gelmon","year":"2011","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.breast.2013.04.006_bib104","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10549-007-9600-1","article-title":"Response to neo-adjuvant chemotherapy in women with BRCA1-positive breast cancers","volume":"108","author":"Byrski","year":"2008","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.breast.2013.04.006_bib105","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1200\/JCO.2008.20.7019","article-title":"Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy","volume":"28","author":"Byrski","year":"2010","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.breast.2013.04.006_bib106","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10549-010-0859-2","article-title":"Effect of BRCA1\/2 mutation on short-term and long-term breast cancer survival: a systematic review and meta-analysis","volume":"122","author":"Lee","year":"2010","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"10.1016\/j.breast.2013.04.006_bib107","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/SAP.0b013e3181dba8dc","article-title":"Surgical and financial implications of genetic counseling and requests for concurrent prophylactic mastectomy","volume":"64","author":"Murphy","year":"2010","journal-title":"Ann Plast Surg"},{"issue":"6","key":"10.1016\/j.breast.2013.04.006_bib108","doi-asserted-by":"crossref","first-page":"397","DOI":"10.7326\/0003-4819-144-6-200603210-00006","article-title":"Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation","volume":"144","author":"Anderson","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.breast.2013.04.006_bib109","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3233\/BD-2007-27109","article-title":"A principle-based approach to ethical issues in predictive genetic testing for breast cancer","volume":"27","author":"Quillin","year":"2006","journal-title":"Breast Dis"},{"issue":"Suppl 1","key":"10.1016\/j.breast.2013.04.006_bib110","doi-asserted-by":"crossref","first-page":"i60","DOI":"10.1093\/annonc\/mdq668","article-title":"Social and ethical implications of BRCA testing","volume":"22","author":"Surbone","year":"2011","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.breast.2013.04.006_bib111","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/sj.ejhg.5200668","article-title":"Men at risk of being a mutation carrier for hereditary breast\/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing","volume":"9","author":"Lodder","year":"2001","journal-title":"Eur J Hum Genet."},{"issue":"7","key":"10.1016\/j.breast.2013.04.006_bib112","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1467-9566.2006.00515.x","article-title":"Guilt, blame and responsibility: men's understanding of their role in the transmission of BRCA1\/2 mutations within their family","volume":"28","author":"Hallowell","year":"2006","journal-title":"Sociol Health Illn"},{"issue":"11","key":"10.1016\/j.breast.2013.04.006_bib113","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1002\/cncr.21479","article-title":"The impact of receiving genetic test results on general and cancer-specific psychologic distress among members of an African-American kindred with a BRCA1 mutation","volume":"104","author":"Kinney","year":"2005","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.breast.2013.04.006_bib114","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1089\/gte.2004.8.240","article-title":"Psychological impact of genetic testing for breast cancer susceptibility in women of Ashkenazi Jewish background: a prospective study","volume":"8","author":"Andrews","year":"2004","journal-title":"Genet Test"},{"issue":"1","key":"10.1016\/j.breast.2013.04.006_bib115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ajmg.a.10868","article-title":"Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients","volume":"116A","author":"Claes","year":"2003","journal-title":"Am J Med Genet A"},{"issue":"5","key":"10.1016\/j.breast.2013.04.006_bib116","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s10897-009-9232-1","article-title":"The effect of BRCA gene testing on family relationships: A thematic analysis of qualitative interviews","volume":"18","author":"Douglas","year":"2009","journal-title":"J Genet Couns"},{"issue":"13","key":"10.1016\/j.breast.2013.04.006_bib117","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1002\/cncr.26471","article-title":"When parents disclose BRCA1\/2 test results: their communication and perceptions of offspring response","volume":"118","author":"Bradbury","year":"2012","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.breast.2013.04.006_bib118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pon.1582","article-title":"Psychological adjustment among male partners in response to women's breast\/ovarian cancer risk: a theoretical review of the literature","volume":"19","author":"Sherman","year":"2010","journal-title":"Psychooncology"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977613000878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977613000878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:31:04Z","timestamp":1760776264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977613000878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":118,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0960977613000878"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2013.04.006","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Practical aspects of genetic counseling in breast cancer: Lights and shadows","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2013.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}